Transplant Genomics
Woodland Hills
About Transplant Genomics
Transplant Genomics is a biotech company that focuses on improving organ transplant outcomes with noninvasive serial monitoring guided by genomics. Its extensive development pipeline includes diagnostic and predictive tests for kidney and liver graft dysfunction, the use of multiple sample types and technology platforms, companion diagnostics for immune suppressants and immune status tests.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $6.2M
- Funding stage: M&A
- Last round: Series Unknown (Nov 2014)
- Website: trugraf.com
- Phone: 617-733-0757
Industries & Categories
Biotechnology, Genetics, Health Diagnostics, Medical
Social Profiles
Canonical: https://fsome.com/organization/transplant-genomics-2415964 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.